In humans, oxidative phosphorylation (OXPHOS), the cellular energy producer, harbors ~90 nuclear DNA (nDNA)-and mitochondrial DNA (mtDNA)-encoded subunits. Although nDNA-and mtDNA-encoded OXPHOS proteins physically interact, their transcriptional regulation profoundly diverges, thus questioning their co-regulation. To address mtDNA-nDNA gene coexpression, we analyzed ~8,500 RNA-seq Gene-Tissue-Expression (GTEx) experiments encompassing 48 human tissues. We found overall positive cross-tissue mtDNA-nDNA OXPHOS gene co-expression. Nevertheless, alternatively-spliced variants, as well as certain OXPHOS genes, did not converge into the main OXPHOS gene cluster, suggesting tissue-specific flavor of OXPHOS gene expression. Finally, unlike non-brain body sites, and neocortex and cerebellum ('mammalian' brain), negative mito-nuclear expression correlation was found in the hypothala us, asal ga glia a d a ygdala a ie t rai . A alyses of co-expression, DNaseseq and ChIP-seq experiments identified candidate RNA-binding genes and CEBPb as best explaining this phenomenon. We suggest that evolutionary convergence of the 'mammalian' brain into positive mtDNA-nDNA OXPHOS co-expression reflects adjustment to novel bioenergetics needs.
Introduction
Energy production via mitochondrial oxidative phosphorylation (OXPHOS) is the major source of energy in most human tissues. OXPHOS employs five multi-subunit protein complexes harboring more than 80 nuclear DNA (nDNA)-encoded proteins, as well as 13 mitochondrial DNA (mtDNA)-encoded subunits 1 . As many OXPHOS genes were transferred from the ancestral mitochondrial genome to the host nuclear genome during the course of evolution, these genes are currently located throughout the human karyotype and are individually regulated 2 . In contrast, human mtDNA-encoded genes have retained their prokaryotic ancestral co-transcription strategy in heavy-and light-strand polycistrons 3 . These two polycistrons dramatically differ in their coding content, with the first harboring 12 of the 13 OXPHOS subunits, and the remaining protein, the ND6 subunit of OXPHOS complex I, NADH ubiquinone oxidoreductase, being encoded by the light strand. Such prokaryotic-like expression is thought to be regulated mainly by a dedicated mitochondrially targeted RNA polymerase (POLRMT) and two transcription factors (TFAM and mtTF2B) 4 . Although several known regulators of nuclear gene transcription were recently shown to be imported into the mitochondria and regulate mtDNA transcription [5] [6] [7] [8] , the dispersal of OXPHOS genes throughout the human genome, in addition to their division between the nuclear and cytoplasmic genomes, apparently interferes with transcriptional co-regulation.
Are OXPHOS gene transcripts co-regulated? It was previously argued that genes encoding factors that belong to the same pathway tend to be co-regulated at the transcriptional level 9, 10 . This hypothesis has been tested for nDNA OXPHOS genes at the level of gene expression pattern using Affymetrix chips 11 . In that study, the authors argued for the tendency of genes encoding OXPHOS subunits to co-express at the mRNA level. The authors further argued that such co-expression tended to be subdivided according to the five OXPHOS protein complexes, i.e., complex I, succinate dehydrogenase (complex II), cytochrome bc1 (complex III), cytochrome oxidase (complex IV) and ATP synthase (complex V). Nevertheless, although the gene expression chip profiles considered represented multiple human tissues (N=79), they were derived from only few individuals and, therefore, cannot provide real insight into OXPHOS gene co-expression in the different tissues. Additionally, as these experiments did not employ mtDNA probes and did not consider tissue-specific splice variants, gaps in our understanding of OXPHOS gene regulation across and within tissues remain. Other analysis that included mtDNA genes was limited to only a few genes 12 . Recent analysis of RNA-seq data from the Cancer Genome Atlas (TCGA) sample collection enabled Reznik et al. (2017) to assess the expression patterns of mtDNA-encoded OXPHOS subunits and corresponding nDNA-encoded OXPHOS genes in a variety of cancer types and in normal adjacent samples 13 . Although co-expression of OXPHOS subunits encoded by the two genomes was identified in several cancer types, one cannot easily extend these observations to describe the pattern of OXPHOS gene expression across normal healthy tissues.
Despite the fundamental role played by mitochondrial bioenergetics in eukaryotic metabolism, tissue differences were reported in mitochondrial number, morphology and network interactions 14 . Such variation, along with tissue diversity in terms of bioenergetics requirements, interferes with any generalization concerning OXPHOS gene co-regulation to all tissues. Indeed, variation in OXPHOS function across tissues was demonstrated in several model organisms 15 . Furthermore, the identification of tissue-specific subunit paralogs in cytochrome coxidase (complex IV) 16, 17 , as well as recent identification of tissue-specific splice variants in the complex I subunit NDUFV3 [18] [19] [20] , provided the first clues of possible tissue variation, and even tissue-specificity, in OXPHOS subunit composition. Although these pieces of evidence support variation in OXPHOS gene expression across tissues, the extent of this phenomenon has yet to be assessed.
Here, we utilized the human RNA-seq gene expression GTEx database 21, 22 , containing experimental information collected from multiple body sites from over 500 donors, to assess coexpression patterns of the entire set of nDNA-and mtDNA-encoded OXPHOS genes across a variety of body sites (N=48). Overall tissue expression patterns were correlated between the two genomes, and candidate transcriptional and post-transcriptional regulatory factors that could best explain the observed co-expression were identified. Unexpectedly, negative mitonuclear gene expression correlation in 'ancient' brain tissues was found. These results underline a profoundly different mode of mitochondrial gene expression regulation in brain tissues associated with the a ie t reptile rai (i.e, hypothalamus, basal ganglia, amygdala and upper spinal cord), in stark difference to all other body sites, as well as to brain regions that were specifically expanded during mammalian evolution (i.e., cortex, frontal cortex, cerebellar hemispheres, and cerebellum) 23, 24 . Finally, our analysis unearthed a group of structural OXPHOS genes and splice variants that co-express in a tissue-dependent manner, supporting the existence of tissue-specific expression of certain OXPHOS genes.
Results
nDNA OXPHOS structural genes are generally co-expressed. Since proteins that participate in the same biochemical activity tend to co-express at the RNA level 9, 10 , we hypothesized that mtDNA and nDNA-encoded OXPHOS genes (Supplementary Table 1 ) would likely be co-expressed. To test this hypothesis, we assessed correlation between OXPHOS gene expression across multiple human body sites using the publically available GTEx RNA-seq expression portal.
For the sake of consistency, and to avoid sample size-related effects, we only considered those body sites for which expression data from at least 50 samples from unrelated donors was available (N=48 tissues), and extracted expression data for OXPHOS genes, which were then normalized for age, gender and cause of death ( Supplementary Fig. 1 ). Next, we calculated expression pattern correlations Spear a s rank correlation efficient (r s )) for all possible OXPHOS gene pairs across the selected 48 human body sites. A thousand replicates of this procedure enabled calculation of the median Spearman's rank correlation coefficient. When a significant correlation (p<0.05) was achieved in more than 950 (95%) of the iterations, we considered the correlation to be significant. These calculations generated clusters of coexpressed OXPHOS genes (Supplementary Table 2) , here presented as a heat map (Fig. 1) .
Firstly, such analysis revealed high similarity in the expression pattern of all nDNA-encoded OXPHOS genes, excluding eight genes with known paralogs (i.e., COX6A1, COX6A2, COX4I2, COX7A1, COX8C, COX7B2, COX6B2 and ATP5L2). This further supported the co-expression of nDNA-encoded OXPHOS genes, as previously suggested 11 .
Although overall clustering of gene expression was observed between nDNA-encoded OXPHOS genes, we noticed that nine genes (NDUFS4, NDUFC2, NDUFA11, SDHC, SDHD, COX7A2, ATP5G2, ATP5IF1 and ATP5E) showed relatively lower similarity to the rest of the nDNA-encoded OXPHOS genes than did others (hereafter called the 'lower similarity cluster') ( Fig. 1) . This suggested that a subset of the OXPHOS structural subunits are differentially expressed in certain tissues. To test this hypothesis, we further analyzed similarity in OXPHOS gene expression patterns in each of the 48 different tissues from the tested human subjects (see 'Analysis of tissue-specific coexpression' in Methods). Firstly, five of the above-mentioned genes (COX7A2, NDUFS4, NDUFC2, NDUFA11 and ATPIF1) showed high similarity to the 68 nDNA-encoded OXPHOS genes in the main OXPHOS cluster (Fig. 1) only in brain tissues, consistent with some degree of tissue specificity among integral subunits of the OXPHOS system. Secondly, the expression of COX7A1 and COX6A2, previously identified as heart-and skeletal muscle-specific paralogs of COX7A2 and COX6A1, respectively 25 , showed high similarity to the main OXPHOS gene cluster in 19 of the 48 tested tissues (Supplementary Fig. 2 ). This shared tissue-dependent co-expression pattern of COX7A1 and COX6A2 with the main OXPHOS gene cluster, along with the structural roles of COX7A1 and COX6A2 in complex IV dimer assembly 26 , suggests that these subunits function as part of the OXPHOS system in a wider range of tissues than previously thought. Taken together, although general co-expression of nDNA-encoded OXPHOS genes is observed, certain nDNAencoded OXPHOS genes vary in tissue range in which they display co-expression with the main OXPHOS gene cluster. Notably, tissue specific expression of OXPHOS transcripts is further discussed below.
Genes coding known factors of OXPHOS protein complex assembly are not co-expressed with OXPHOS genes. We next assessed whether the high similarity between gene expression patterns of nDNA-encoded OXPHOS protein subunits is shared by known assembly factors of OXPHOS protein complexes (Supplementary Table 1) . To this end, we employed the expression correlation analysis described above, this time including genes encoding assembly factors of OXPHOS complexes ( Fig. 2A) . In general, the correlation of tissue expression patterns between nDNA-encoded OXPHOS genes was significantly stronger than was correlation with the assembly factors (median intra-OXPHOS correlation=0.570, median OXPHOS-assembly factor correlation=0.261, MWU=8.9E4, p<1E-100) (Fig. 2B) , with one exception, namely the expression pattern of assembly factor UQCC2 clustered with 58 of the nDNA-encoded OXPHOS genes ( Fig. 2A ). The remaining 27 nDNA-encoded OXPHOS genes, including the eight redundant paralogs and the 'lower similarity cluster' genes, equally clustered with both OXPHOS and assembly factor genes. Hence, taken together, gene co-expression is highly specific for OXPHOS structural subunits (Fig. 1). nDNA and mtDNA-encoded OXPHOS genes have correlated expression patterns. In order to analyze mtDNA gene expression while using whole transcriptomes, one has to consider that during the course of evolution mtDNA fragments migrated to the nucleus and integrated in the nuclear genome 27, 28 . Hence, it is possible that some of the RNA-seq reads may have originated from these nuclear mitochondrial pseudogenes (NUMTs). The GTEx consortium has already taken measures to identify NUMT reads and mark them as mitochondrial pseudogenes; these were excluded from further analyses. Our analysis (after NUMT exclusion) revealed high correlation between the expression patterns of all OXPHOS genes encoded by the mtDNA, with lower expression similarity observed for the ND6 gene (Fig. 1) . Such a pattern could be attributed to the polycistronic nature of mtDNA transcription: Whereas 12 out of the 13 mtDNA protein-coding genes are encoded by the heavy strand, ND6 is the only protein-coding gene encoded by the light strand in human mtDNA.
Although forming a distinct expression cluster, the expression of all mtDNA-encoded genes was positively correlated with nDNA-encoded OXPHOS genes, apart from four redundant paralogs of OXPHOS genes (ATP5L2, COX6B2, COX7B2 and COX8C) and six OXPHOS genes belonging to the 'lower similarity cluster' (SDHC, SDHD, NDUFS4, ATP5G, NDUFA11 and ATP5E) (Fig. 1 ). This supports a general cross-tissue mtDNA-nDNA co-expression.
It is logical that genes encoding subunits of certain OXPHOS complexes tend to co-regulate.
Indeed, in agreement with a previous report 11 , we found that subunits belonging to the same OXPHOS complex were significantly more positively correlated than were OXPHOS genes encoding subunits belonging to different complexes (median within-complex correlation=0.625, median between-complex correlation=0.605, MWU=3.7E6, p<10E-6). Notably, such strong within-complex expression correlation was evident in OXPHOS complexes I, II, IV and V, although only marginally significant differences in correlation values were obtained for OXPHOS complex III (Supplementary Table 3 ).
We next compared the correlation between the expression patterns of pairs of OXPHOS genes to the correlation of OXPHOS gene expression with randomly chosen protein-coding genes. As above, each measurement was re-calculated in 1000 replicates. Our results indicate that the correlation value between OXPHOS gene pairs was significantly higher than between OXPHOS and random genes (median=0.54 and median=-0.017, respectively, MWU=0.0, p<1E-100).
Notably, none of the 1000 iterations revealed a higher median correlation value between OXPHOS genes and other random protein-coding genes, as compared to the median correlation between pairs of OXPHOS genes ( Supplementary Fig. 3 ). Similar to the case of the entire set of OXPHOS genes, the correlation of the mtDNA-encoded genes expression with nDNA-encoded OXPHOS genes (median=0.280) was significantly higher than their correlation with genes coding for OXPHOS complex assembly factors (median=-0.018, MWU=4.9E6, p<1E-100) (Fig. 2C ). These findings suggest that when considering all analyzed tissues, gene expression co-regulation of mtDNA-and nDNA-encoded OXPHOS genes exists, despite the distinct mtDNA transcription regulatory system. between the expression of mtDNA-and nDNA-encoded OXPHOS ge es ithi a ie t rai regions (median=-0.563) was significantly more negative than the observed correlation between the expression of mtDNA genes and non-structural OXPHOS genes in these tissues (median=-0.098, MWU=1.7E7, p-value<1E-100) ( Fig. 3B . This further suggests a a ie t rai -specific regulatory modulation, which likely impairs the positive co-regulation of OXPHOS genes encoded by the two genomes. We, however, observed several exceptions to this rule. Firstly, the substania nigra and anterior cingulate cortex (Brodmann area 24) presented a mixed/intermediate correlation pattern between the nDNA and mtDNA genes: whereas the expression of some nDNA OXPHOS genes was positively correlated with that of the mtDNA genes, some nDNA genes exhibited anti-correlation with mtDNA genes (Dataset S1). Secondly, the hippocampus, which is considered part of the 'ancient' brain, revealed a generally positive mito-nuclear expression correlation, apart from four nDNA genes (SDHA, NDUFV1, NDUFS2 and NDUFA10), which showed somewhat negative correlation with mtDNA OXPHOS genes in this brain tissue. Notably, the expression patterns of these four genes was highly correlated across all tissues (including the 'ancient' brain) and did not show altered correlation to the mtDNAencoded OXPHOS genes in the 'mammalian' brain tissues, thus showing some similarity between the 'ancient' brain and the hippocampus. Taken together, there is a strong tendency for impairment of mito-nuclear co-expression in 'ancient brain tissues.
Different lactate dehydrogenase isoforms are expressed in the 'ancient brain. We hypothesized that the negative correlation in gene expression between mtDNA and nDNA OXPHOS genes could reflect a limited range of assembled complexes that harbor both nDNA and mtDNA-encoded subunits at the protein level (Supplementary Table 4 ). This, in turn, could restrain the activity range of the OXPHOS system. One prediction that stems from this hypothesis is that 'ancient' brain tissues should have an altered balance between aerobic and anaerobic metabolism, relati e to a alia rai . Such an alteration may be reflected in the expression of lactate dehydrogenase (LDH), a key enzyme that plays pivotal role in determining the fate of pyruvate. Specifically, LDH activity is important for the decision of whether pyruvate enters the tricarboxylic acid (TCA) cycle (in the form of either acetyl-CoA or oxaloacetate), thus providing electron carriers for the OXPHOS, or alternatively, whether pyruvate is fermented into lactate to maintain the NAD + pool and sustain glycolysis. LDH acts as a tetramer that can contain a combination of different isoforms, including LDH-1 (the M 4 isoform), which harbors subunits encoded only by the gene LDHA and is more efficient in catalyzing pyruvate reduction into lactate, and the LDH-5 (H 4 isoform) that harbors subunits encoded only by the LDHB gene, which is more efficient in catalyzing lactate oxidation into pyruvate 31, 32 . Our analysis indicates that while in the vast majority of body sites (all non-brain and 'mammalian' brain tissues), LDHA and LDHB have similar expression levels ( Supplementary Fig. 5 ), the 'ancient' brain exhibits with an increased level of LDHA expression (~1.5-2.0-fold as compared to the tissue expression average) and a decrease in LDHB expression, to a similar extent. Interestingly, the latter pattern was also observed in the substantia nigra, the anterior cingulate cortex and the hippocampus, which have all showed some degree of anti-correlation between mtDNA-and nDNA-encoded OXPHOS genes that was not observed in the 'mammalian' brain tissues (Fig. 3D) . These results are consistent with our suggestion, that the 'ancient' brain-specific mito-nuclear expression pattern correlates with a change in the expression pattern of LDH subunit genes.
Candidate factors that best explain the co-regulation of nDNA-encoded OXPHOS genes. The identification of co-expression patterns in OXPHOS genes suggests a common underlying mechanism. Previous in sillico motif searches of genomic regions upstream to OXPHOS genes revealed enrichment of several transcription factor binding motifs 11 .
Although pioneering, such analysis lacked in vivo validation. Hence, as the first step to identifying candidates contributing to the common mechanism underlying the co-expression of OXPHOS genes, we aimed at identifying cis-regulatory elements upstream of all nDNA-encoded OXPHOS genes. To this end, we analyzed DNase-seq experimental results from 125 human cell lines generated by the Encyclopedia of DNA Elements (ENCODE) consortium and identified DNase genomic footprints (DGFs) in a window of 1000 base pairs upstream to the translation start site (TSS) of all nDNAencoded OXPHOS genes ( Supplementary Fig. 6 ). Then, to correlate in vivo binding sites of transcription factors (TFs) to the identified DGF sites, we analyzed available chromatin immunoprecipitation (ChIP)-seq results for 161 TFs from ENCODE, and assessed the overlap between the above-mentioned DGF sites and ChIP-seq peaks (Supplementary Tables 5,6 and Supplementary Fig. 6 ). This allowed us to identify TFs that commonly bind sites upstream to OXPHOS genes, thus providing the best candidates for explaining, at least in part, the co-expression of OXPHOS genes. Our results indicate that OXPHOS genes whose expression pattern strongly correlated also presented higher degrees of shared TF binding sites than they did with the redundant paralogs of OXPHOS genes ( Fig. 1, Supplementary Fig. 6 ). Twelve RNA-binding proteins and CEBPb are the best candidates to explain the co-expression pattern of mtDNA-and nDNA-encoded OXPHOS genes across human body sites. We next sought for the best candidate factors to explain the co-expression of mtDNA and nDNA OXPHOS genes. To this end, we focused our analysis on a set of genes encoding both TFs and genes encoding predicted RNA-binding proteins with known mitochondrial localization in human cells.
Notably, the TFs included in this list were experimentally shown in vivo to bind the mtDNA [5] [6] [7] [8] 33 .
To identify the factors that best explain the increase in mito-nuclear gene expression correlation, we sought factors whose expression positively correlated with OXPHOS genes encoded by both the mtDNA and the nDNA in most tissues, except for a ie t rai body sites (in which mito-nuclear correlation was negative). Twelve genes which encode predicted RNA- (Fig. 4) . Interestingly, one of these genes (SLIRP) was previously shown to promote the stability of mRNA transcripts of both nDNA-and mtDNA-encoded OXPHOS genes 34 . We, therefore, suggest that products of these genes serve as the best candidates to participate in post-transcriptional regulation of nDNA OXPHOS gene expression. Their negative correlation with mtDNA-encoded OXPHOS genes in 'ancient' brain tissues, as opposed to their positive correlation with mtDNA gene expression in other tissues, support the putative participation of these genes in active uncoupling of mito-nuclear co-regulatio i the a ie t rai (Fig. 5) .
Intriguingly, the expression pattern of a single gene in our list of 117 genes, CEBPb, was negatively correlated to the expression of both mtDNA and nDNA OXPHOS genes in most human tissues. This constitutively negative expression correlation with genes of both genomes tended to be stronger in body sites with highly positive mito-nuclear expression correlation, such as spleen, adrenal gland and the cerebellar hemisphere, but was lost specifically in the 'ancient' brain (Fig. 4) . CEBPb encodes for the CCAAT/Enhancer-Binding Protein Beta (CEBPb) and was experimentally shown to modulate gene expression regulation of nDNA-encoded OXPHOS genes 35 . We and others have shown in vivo binding of this protein to human mtDNA 5, 36 . We found that CEBPb in vivo bound 51% of the candidate promoter regions upstream to nDNA OXPHOS genes, and had a significantly positive effect on their correlation of expression patterns across human tissues (0.036 SCU). We, therefore, argue that CEBPb is likely a negative regulator (candidate repressor) of OXPHOS gene expression that concomitantly acts on both genomes to coordinate OXPHOS gene expression (Fig. 5) .
The landscape of tissue-specific expression patterns of splice variants of OXPHOS subunits.
Until this point, we demonstrated co-expression of OXPHOS genes encoded by the nucleus and by the mtDNA across human tissues. Whereas most OXPHOS genes tend to co-express, we found unexpected evidence for seven OXPHOS subunits whose expression correlated with the rest of the OXPHOS genes only in a subset of tissues ( Supplementary Fig. 2 ). Although this reduction in correlation to the main OXPHOS cluster (Fig. 1) was not tissue-specific, as compared to the known tissue-specific redundant paralogs of OXPHOS complex IV, it implied that there might be other additional attributes of tissue specificity in the expression of OXPHOS genes.
Recent findings revealed tissue-dependent inclusion of two splice isoforms of NDUFV3, a structural subunit of OXPHOS complex I [18] [19] [20] . Although interesting, it is yet unclear whether this finding reflects an exception or rather is indicative of a much wider phenomenon reflecting tissue-specific expression of splice isoforms of OXPHOS structural subunits. As a first step to assess the extent of this phenomenon, we analyzed the expression correlation patterns of in vivo-identified splice variants of all nDNA-encoded OXPHOS genes across and within the 48 body sites analyzed in the current study.
We analyzed expression pattern correlations among OXPHOS transcripts (including all splice variants) across all tested body sites, while employing the same analysis stages as used for analysis of gene expression patterns. Such analysis underlined the main cluster of OXPHOS gene transcripts (Fig. 6A) . We found that this cluster harbors at least one splice variant representing the known canonical proteins of 63 of the 84 total nDNA-encoded OXPHOS genes (UniProt definition) (termed 'canonical transcripts'). This 'main OXPHOS cluster' was used as a reference for identifying tissue-specific expression patterns of OXPHOS transcripts in a tissue-by-tissue analysis ( Fig. 6B and Supplementary Dataset 2) . This approach enabled the identification of canonical transcripts representing five additional OXPHOS subunits (COX6A2, NDUFA4, NDUFC1, COX7A1 and COX7C) that co-expressed along with the main OXPHOS cluster in nearly a third (15) of the tested body sites. This implies that transcripts from 16 OXPHOS subunits (including the eight redundant paralogs) co-express with the main OXPHOS cluster only in certain tissues.
Hence, eight non-redundant OXPHOS subunits (Fig. 1) have some degree of tissue-specific expression.
Next, we closely inspected the main OXPHOS cluster, and noticed that many of the subunits were represented, either uniquely or additionally, by transcripts other than the canonical transcript. This led us to revisit the canonical sequences of all OXPHOS subunits and assess their expression patterns. To this end, we used all the UniProt canonical isoforms as query sequences to identify their co-expression with the main OXPHOS cluster in a minimum of one tissue. In the case of subunits whose known canonical isoform did not co-express with the main OXPHOS cluster in any tissue, we screened for OXPHOS co-expression of non-canonical splice isoforms representing these genes. Furthermore, in cases where the subunit sequence is known to harbor a mitochondrial localization signal, we used TargetP 1.1 to test whether the splice isoforms maintained their propensity for mitochondrial localization by more than 5%
(http://www.cbs.dtu.dk/services/TargetP/). Our results indicate that six OXPHOS genes had such non-canonical alternatively spliced isoforms (NDUFC2 (two alternative isoforms), ATP5J2 (two alternative isoforms), NDUFA2, NDUFB11, NDUFB6 and NDUFA3). To further consider such noncanonical transcripts as the main transcripts of these subunits, it is logical to expect that these new sequences will not affect domains of interaction with neighboring subunits in the 3D structure of the relevant OXPHOS complex. To this end, we analyzed five of the six genes with such transcripts, encoding subunits of OXPHOS complex I, for which high-resolution 3D structures from mammal sources have been recently provided 37, 38 . NDUFC2 contains two trans-membrane alpha-helixes that participate in physical interaction with the subunits ND2, NDUFC1
and NDUFA11. None of the two splice isoforms altered these two helixes. The splice isoform of NDUFA2 is predicted to lack a single beta-strand and a single alpha-helix in the C-terminal region of the protein. However, it is unclear whether these elements play essential role in interactions with the neighboring core subunit NDUFS1. The splice variant of NDUFB11 is not predicted to alter either of the two alpha-helixes that are likely important for interactions with ND4, NDUFB10 and NDUFB8. Neither of the two alpha-helixes of NDUFB6, including the transmembrane alpha-helix that is important for its interaction with ND5, are altered in the alternatively spliced isoform. The two helixes in NDUFA3 that physically interact with ND1 are not predicted to change in the splice isoform either. Taken together, we propose that such noncanonical isoforms should be accepted as revised canonical isoforms of the analyzed subunits (Table 1) .
Discussion
In the current study, we quantitatively analyzed the expression of OXPHOS genes encoded by the mitochondrial and nuclear genomes in 48 human body sites. Although this detailed analysis supported correlations between OXPHOS genes, it did not support correlation of OXPHOS genes with the majority of OXPHOS complex assembly factors, suggesting that co-regulation is limited to the structural subunits of the OXPHOS system in the mitochondrial and nuclear genomes. and the activity of succinate dehydrogenase (complex II) in the cortex than in the hypothalamus 40 . This is interesting, since complex II contains only nDNA-encoded subunits, and complex I harbors subunits encoded by both the mitochondrial and nuclear genomes. As such, disruption of mito-nuclear co-regulation in the 'ancient' brain tissues may be accompanied by changes in mitochondrial activity. Secondly, mtDNA depletion in the rat striatum (an 'ancient' brain region) led to a significantly worse mitochondrial phenotype as compared to mtDNA depletion in the rat neocortex 41 . These pieces of evidence suggest that in 'ancient' brain tissues, the amount of actively assembled mito-nuclear OXPHOS complexes (complexes I, III, IV and V) is lower than in the rest of the body (Supplementary . Nevertheless, proving this interpretation will require additional study.
The specific disruption of mito-nuclear co-regulation in 'ancient' brain tissues suggests an active . Our results indicate that the expression of a gene encoding one such TF, CEBPb, is negatively correlated with the expression of both mtDNA-and nDNA-encoded OXPHOS genes in all body sites, apart from the 'ancient' brain, where CEBPb specifically lost its negative expression correlation to OXPHOS genes in both genomes. We also found that CEBPb binds regulatory elements of many nDNA-encoded OXPHOS genes and significantly affected the expression correlation between pairs of nDNA-encoded OXPHOS genes. Still, further work is required to identify the regulatory system that govern this phenomenon.
Despite the overall co-expression of OXPHOS genes, distinct clustering of mtDNA gene
expression was identified in all tested tissues. This is not surprising, as core-regulators of mtDNA gene expression are dedicated to mitochondrial function and have no clear impact on nuclear gene regulation 45 . While focusing solely on mtDNA genes, ND6 had lower correlation scores with rest of the genes encoded by this genome. This is consistent with ND6 being the only mRNA encoded by the light mtDNA strand, which in humans has a separate promoter from the heavy mtDNA strand, that harbors most mtDNA genes. It would, therefore, be of great interest to assess correlation in mtDNA gene expression in birds and amphibians, where a bidirectional mtDNA promoter governs the transcription of both mtDNA strands 46, 47 . As our expression correlation was observed at the population level, this analysis awaits the availability of RNA-seq from multiple unrelated individuals from these taxa.
RNA-seq analysis enabled the identification of both canonical and non-canonical splice variants of all nDNA-encoded OXPHOS genes, and assessment of their expression patterns in human body sites. Our analysis showed that while most OXPHOS genes co-expressed in most tissues, such co-expression clusters were not always represented by a combination of the known canonical gene transcripts. Close inspection revealed that six genes encoding OXPHOS subunits, including NDUFC2, ATP5J2, NDUFA2, NDUFB11, NDUFB6 and NDUFA3, were mostly represented by a different, non-canonical splice variant, resulting in a non-canonical protein. Therefore, based on clustering and abundance in the different tissues, we offer a revised list of OXPHOS canonical transcripts, which will be useful for future analyses of OXPHOS genes (Table 1) . Our analysis also revealed that the expression of nearly a quarter of all OXPHOS subunits was either clearly tissue-specific or correlated with the main OXPHOS co-expression cluster only in a subset of tissues. This suggests that the subunit composition of several OXPHOS complexes varies among tissues. This hypothesis is supported by the existence of tissue-specific paralogs of cytochrome C-oxidase (complex IV) 48, 49 and by the recent identification of a tissue-specific splice variant of the complex I subunit NDUFV3, also at the protein level [18] [19] [20] . Notably, such interpretation awaits proteomics analysis of multiple human tissues that potentially will differentiate paralogs from splice isoforms. Regardless, our analyses provide a first glance into the landscape of the tissue expression pattern of OXPHOS subunit splice variants, and constitutes the first assessment of this phenomenon.
In summary, to the best of our knowledge, we have presented here the most comprehensive analysis to date of the OXPHOS transcription regulatory landscape across multiple human tissues. We discovered overall co-regulation of the mitochondrial and nuclear genomes, which was disrupted in the 'ancient' brain but not in the 'mammalian' brain, possibly due to an uncoupling of mitochondrial post-transcriptional regulation and by a loss of transcription coordination of both genomes. We interpreted this finding as reflecting adaptation of the 'mammalian' brain to newly emerging energy needs during evolution. Our detailed analysis of cis-regulatory elements of all nDNA-encoded OXPHOS genes revealed several candidate transcription and post-transcription regulators that might provide a partial explanation to the observed co-regulation of OXPHOS subunits. Finally, we revisited the list of canonical OXPHOS transcripts and provided a comprehensive view of tissue-specific transcripts, thus suggesting tissue variability not only in the regulatory pattern but also in the composition of OXPHOS complexes.
Materials and Methods
Source of RNA-seq data in RPKM (Reads Per Kilobase per Million mapped reads): Gene expression data and individual information, including gender and cause of death, were obtained from the publicly available data at the GTEx portal (www.gtexportal.org). Individual ages (rather than age groups) were obtained from the GTEx-authorized data table for donor information (pht002742.v6.p1.c1), 'age' column (phv00169063.v6.p1.c1).
Extraction of alternatively spliced isoforms:
The expression patterns of splice variants of the tested genes were extracted from the publically available data at the GTEx portal. Only proteincoding variants, determined according to the Ensemble genome browser (www.ensembl.org),
were considered in our analysis of co-expression.
NUMT exclusion: One source of contamination of our analyzed mtDNA gene expression data is sequencing reads of ancient mtDNA fragments that were transferred to the nDNA during the course of evolution 27, 28 .
To control for such contamination, GTEx used nuclear mitochondrial pseudogene transcript sequences as their reference transcriptome (appears as mtXPN in the GTEx data, where X represents the mitochondrial gene and N stands for the number of the pseudogene). Therefore, reads that had higher similarity scores to any given pseudogene, as compared to the reference mtDNA gene, were excluded from the reads count for mtDNAencoded genes. To further control for NUMTs, we used the normalized read counts (reads per kilo-base per million reads -RPKM) available in the GTEx consortium data files as our raw data.
According to GTEx documentation, the read alignment distance was ≤6 (i.e., sequence alignments must not contain more than six mismatches), thus notably reducing possible contamination by NUMT reads.
RPKM to TPM conversion:
The RPKM value for a given gene "i" in each library (each sample) was converted to TPM as previously described 50 , using the following formula:
Control for age, gender and cause of death: To control for the possible contribution of age, gender and cause of death to gene expression patterns, we normalized for these factors using linear regression (see below), such that the calculated residual TPM reflected age/gender/causeof-death-independent gene expression. Notably, we compared the vectors of residual TPMs to obtain Spearman correlation scores between each pair of tested genes.
Gene/transcript specific linear regression: To obtain the residual gene expression (i.e., age/gender/cause of death-independent values), we considered all these factors as independent regressing agents in a least-square linear regression model. The age variable was obtained as a continuous factor, whereas gender and cause-of-death were categorical factors. Fig. 1 ).
Clustered heat maps construction:
The median Spearman's rank correlation coefficient between the pairs of genes/transcripts under consideration were used to create a distance matrix for hierarchical clustering. To construct heat maps for each of the analyzed tissues, we used the gene/transcript order that was obtained from the hierarchal clustering generated while analyzing the total expression pattern across all tissues. Additionally, while constructing tissue-specific correlation distance matrixes, we considered all samples available for the tested tissue. Statistical tools and data visualization: All statistical analyses and data visualization were performed using Python 2.7 scipy.stats, pandas, matplotlib and seaborn packages (Dataset S3).
Analysis of tissue-specific co-expression:
Validations to the performance of the Python scripts were performed using STATISTICA 12.
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